Kimito Suemasu

1.6k total citations
39 papers, 1.1k citations indexed

About

Kimito Suemasu is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Kimito Suemasu has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Cancer Research and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Kimito Suemasu's work include Breast Cancer Treatment Studies (18 papers), Estrogen and related hormone effects (11 papers) and Breast Lesions and Carcinomas (11 papers). Kimito Suemasu is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), Estrogen and related hormone effects (11 papers) and Breast Lesions and Carcinomas (11 papers). Kimito Suemasu collaborates with scholars based in Japan, Switzerland and Australia. Kimito Suemasu's co-authors include Yasuhiro Higashi, Kei Nakachi, Masafumi Kurosumi, Kazue Imai, Kenji Suga, Hiroyuki Takei, Kaname Kawajiri, Osamu Gotoh, Junko Watanabe and Yasuo Ohashi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Kimito Suemasu

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimito Suemasu Japan	17	441	352	331	263	255	39	1.1k
Patrizia Miodini Italy	18	331 0.8×	283 0.8×	322 1.0×	419 1.6×	399 1.6×	42	1.0k
Matteo Lazzeroni Italy	22	706 1.6×	239 0.7×	547 1.7×	585 2.2×	276 1.1×	86	1.5k
R Serreyn Belgium	17	267 0.6×	194 0.6×	137 0.4×	148 0.6×	77 0.3×	32	861
Mitsunori Sasa Japan	24	785 1.8×	277 0.8×	480 1.5×	564 2.1×	491 1.9×	87	1.7k
Abbie Lundgreen United States	25	486 1.1×	240 0.7×	441 1.3×	746 2.8×	213 0.8×	43	1.6k
Carola M. Zalles United States	19	274 0.6×	238 0.7×	354 1.1×	253 1.0×	240 0.9×	41	824
Qing Lü China	18	268 0.6×	82 0.2×	173 0.5×	414 1.6×	484 1.9×	36	1.3k
Masato Ohshima Japan	19	163 0.4×	110 0.3×	223 0.7×	307 1.2×	142 0.6×	44	873
Marie‐Ange Mouret‐Reynier France	22	796 1.8×	279 0.8×	704 2.1×	364 1.4×	123 0.5×	81	1.6k
Junmin Zhou United States	19	447 1.0×	206 0.6×	270 0.8×	539 2.0×	63 0.2×	55	1.5k

Countries citing papers authored by Kimito Suemasu

Since Specialization

Citations

This map shows the geographic impact of Kimito Suemasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimito Suemasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimito Suemasu more than expected).

Fields of papers citing papers by Kimito Suemasu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimito Suemasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimito Suemasu. The network helps show where Kimito Suemasu may publish in the future.

Co-authorship network of co-authors of Kimito Suemasu

This figure shows the co-authorship network connecting the top 25 collaborators of Kimito Suemasu. A scholar is included among the top collaborators of Kimito Suemasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimito Suemasu. Kimito Suemasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimozuma, Kojiro, Yasuo Ohashi, Ayano Takeuchi, et al.. (2012). Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Supportive Care in Cancer. 20(12). 3355–3364. 79 indexed citations

Takei, Hiroyuki, Shozo Ohsumi, Kojiro Shimozuma, et al.. (2012). Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04). Breast Cancer Research and Treatment. 133(1). 227–236. 45 indexed citations

Ohsumi, Shozo, Kojiro Shimozuma, Yasuo Ohashi, et al.. (2012). Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology. 82(3). 131–138. 28 indexed citations

Shiroiwa, Takeru, Takashi Fukuda, Kojiro Shimozuma, et al.. (2011). Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery: The N-SAS BC 02 Trial. Value in Health. 14(5). 746–751. 10 indexed citations

Hozumi, Yasuo, Kimito Suemasu, Hidehiro Takei, et al.. (2011). The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study. Annals of Oncology. 22(8). 1777–1782. 40 indexed citations

Aihara, Tomohiko, Kimito Suemasu, Hidehiro Takei, et al.. (2010). Effects of Exemestane, Anastrozole and Tamoxifen on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Early Breast Cancer Patients: Results of N-SAS BC 04, the TEAM Japan Substudy. Oncology. 79(5-6). 376–381. 20 indexed citations

Takei, Hiroyuki, Masafumi Kurosumi, Takashi Yoshida, et al.. (2007). Current trends of sentinel lymph node biopsy for breast cancer —A surgeon’s perspective. Breast Cancer. 14(4). 362–370. 20 indexed citations

Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2007). Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer. 14(1). 16–24. 35 indexed citations

Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2006). 99mTc-Phytate Is Better than 99mTc-Human Serum Albumin as a Radioactive Tracer for Sentinel Lymph Node Biopsy in Breast Cancer. Surgery Today. 36(3). 219–224. 21 indexed citations

10.

Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2006). Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer. 13(2). 179–185. 22 indexed citations

11.

Kono, Seishi, Masafumi Kurosumi, Kaori Kawanowa, et al.. (2006). Immunohistochemical study of the relationship between Ki‐67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease. Pathology International. 56(11). 655–658. 5 indexed citations

12.

Sano, Muneaki, Toshio Tabei, Kimito Suemasu, et al.. (2006). [Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].. PubMed. 33(10). 1411–5. 4 indexed citations

13.

Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2006). Sentinel Lymph Node Biopsy Alone Has No Adverse Impact on the Survival of Patients with Breast Cancer. The Breast Journal. 12(s2). S157–S164. 13 indexed citations

14.

Yoshida, Nobuyuki, Yoko Omoto, Akio Inoue, et al.. (2004). Prediction of prognosis of estrogen receptor‐positive breast cancer with combination of selected estrogen‐regulated genes. Cancer Science. 95(6). 496–502. 68 indexed citations

15.

Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2002). Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer. 9(4). 344–348. 16 indexed citations

16.

Watanabe, Junko, Tsutomu Shimada, Elizabeth M. J. Gillam, et al.. (2000). Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 10(1). 25–33. 148 indexed citations

17.

Nakachi, Kei, et al.. (1998). Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients. Japanese Journal of Cancer Research. 89(3). 254–261. 254 indexed citations

18.

Higashi, Yasuhiro, Kimito Suemasu, Toshio Tabei, et al.. (1998). Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: Report of a case and the role of team medical care. Surgery Today. 28(9). 979–984. 1 indexed citations

19.

Watanabe, Junko, et al.. (1997). Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Pharmacogenetics. 7(5). 419–424. 39 indexed citations

20.

Kurosumi, Masafumi, et al.. (1994). Invasive ductal carcinoma with a predominant intraductal component arising in a fibroadenoma of the breast. Pathology International. 44(12). 874–877. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact